1. Home
  2. PAVS vs QNCX Comparison

PAVS vs QNCX Comparison

Compare PAVS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • QNCX
  • Stock Information
  • Founded
  • PAVS 2004
  • QNCX 2012
  • Country
  • PAVS United States
  • QNCX United States
  • Employees
  • PAVS N/A
  • QNCX N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PAVS Health Care
  • QNCX Health Care
  • Exchange
  • PAVS Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • PAVS 90.2M
  • QNCX 62.0M
  • IPO Year
  • PAVS 2019
  • QNCX 2019
  • Fundamental
  • Price
  • PAVS $1.38
  • QNCX $1.40
  • Analyst Decision
  • PAVS
  • QNCX Strong Buy
  • Analyst Count
  • PAVS 0
  • QNCX 4
  • Target Price
  • PAVS N/A
  • QNCX $9.50
  • AVG Volume (30 Days)
  • PAVS 9.8K
  • QNCX 126.6K
  • Earning Date
  • PAVS 01-01-0001
  • QNCX 03-31-2025
  • Dividend Yield
  • PAVS N/A
  • QNCX N/A
  • EPS Growth
  • PAVS N/A
  • QNCX N/A
  • EPS
  • PAVS N/A
  • QNCX N/A
  • Revenue
  • PAVS $6,544,819.00
  • QNCX N/A
  • Revenue This Year
  • PAVS N/A
  • QNCX N/A
  • Revenue Next Year
  • PAVS N/A
  • QNCX N/A
  • P/E Ratio
  • PAVS N/A
  • QNCX N/A
  • Revenue Growth
  • PAVS N/A
  • QNCX N/A
  • 52 Week Low
  • PAVS $0.32
  • QNCX $0.51
  • 52 Week High
  • PAVS $2.48
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 59.12
  • QNCX 36.52
  • Support Level
  • PAVS $1.32
  • QNCX $1.38
  • Resistance Level
  • PAVS $1.45
  • QNCX $1.49
  • Average True Range (ATR)
  • PAVS 0.06
  • QNCX 0.12
  • MACD
  • PAVS -0.01
  • QNCX -0.01
  • Stochastic Oscillator
  • PAVS 53.33
  • QNCX 7.32

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: